SYNNOTCH Trademark

Trademark Overview

On Tuesday, September 20, 2016, a trademark application was filed for SYNNOTCH with the United States Patent and Trademark Office. The USPTO has given the SYNNOTCH trademark a serial number of 87177576. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Tuesday, March 24, 2020. This trademark is owned by Cell Design Labs, Inc.. The SYNNOTCH trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer, autoimmune disease and immunologic-based disease; Pharmaceutical therapeutic agents for the treatment of cancer, autoimmune disease and immunologic-based disease; Full line of pharmaceutical preparations for the prevention or treatment of cancer, autoimmune disease and immunologic-based disease; Pharmaceutical products, namely, diagnostic reagents for medical purposes; Control reagents for medical laboratory purposes; Control reagents for clinical medical purposes
synnotch

General Information

Serial Number87177576
Word MarkSYNNOTCH
Filing DateTuesday, September 20, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateTuesday, March 24, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 24, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer, autoimmune disease and immunologic-based disease; Pharmaceutical therapeutic agents for the treatment of cancer, autoimmune disease and immunologic-based disease; Full line of pharmaceutical preparations for the prevention or treatment of cancer, autoimmune disease and immunologic-based disease; Pharmaceutical products, namely, diagnostic reagents for medical purposes; Control reagents for medical laboratory purposes; Control reagents for clinical medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 26, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKITE PHARMA, INC.
Party Type22 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSANTA MONICA, CA 90404
Party NameKITE PHARMA, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSanta Monica, CA 90404
Party NameCell Design Labs, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608
Party NameCell Design Labs, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608

Trademark Events

Event DateEvent Description
Tuesday, May 26, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, May 26, 2020ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 29, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 28, 2019EXTENSION 5 GRANTED
Monday, August 26, 2019EXTENSION 5 FILED
Monday, August 26, 2019TEAS EXTENSION RECEIVED
Thursday, March 7, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 7, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 7, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 6, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, March 6, 2019EXTENSION 4 GRANTED
Thursday, February 28, 2019EXTENSION 4 FILED
Wednesday, March 6, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 28, 2019TEAS EXTENSION RECEIVED
Saturday, June 23, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 21, 2018EXTENSION 3 GRANTED
Thursday, June 21, 2018EXTENSION 3 FILED
Thursday, June 21, 2018TEAS EXTENSION RECEIVED
Thursday, February 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 13, 2018EXTENSION 2 GRANTED
Tuesday, February 13, 2018EXTENSION 2 FILED
Tuesday, February 13, 2018TEAS EXTENSION RECEIVED
Thursday, August 24, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 22, 2017EXTENSION 1 GRANTED
Tuesday, August 22, 2017EXTENSION 1 FILED
Tuesday, August 22, 2017TEAS EXTENSION RECEIVED
Tuesday, March 21, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 24, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 24, 2017PUBLISHED FOR OPPOSITION
Wednesday, January 4, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 19, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 14, 2016ASSIGNED TO LIE
Tuesday, December 6, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 6, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 29, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 29, 2016EXAMINER'S AMENDMENT ENTERED
Tuesday, November 29, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 29, 2016EXAMINERS AMENDMENT E-MAILED
Tuesday, November 29, 2016EXAMINERS AMENDMENT -WRITTEN
Saturday, November 19, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, November 19, 2016NON-FINAL ACTION E-MAILED
Saturday, November 19, 2016NON-FINAL ACTION WRITTEN
Friday, November 18, 2016ASSIGNED TO EXAMINER
Monday, September 26, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 23, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

synnotch disease pharmaceutical purposes medical reagents immunologic based treatment cancer autoimmune